Back

Reduction of LDL and Lp (a) under the PCSK9 inhibitor Evolocumab/Alirozumab in patients with familial hypercholesterolemia or manifest atherosclerosis

7 April 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session II - Friday 08:30 - 18:00 - Diabetes/ Lipids/Obesity/Nutrition_Part 2 Lipids EAPC Premium Access EuroPrevent 2017

About the speaker

Photo
Mr Madan Raj Poudel

University Clinic OWL, Bielefeld (Germany)

12 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor S. Okamoto (Tsu, JP)
Abstract
Presentation thumbnail
Professor B. Schwaab (Timmendorfer Strand, DE)
Abstract
Presentation thumbnail
Professor O. Barbarash (Krasnodar, RU)
Abstract
Presentation thumbnail

Access the full session

Session thumbnail
Poster Session II - Friday 08:30 - 18:00 - Diabetes/ Lipids/Obesity/Nutrition_Part 2

The Event

Event poster

EuroPrevent 2017

7 April 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources